Daré Bioscience, Inc.
DARE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $2,808 | $10,000 | $0 |
| % Growth | -99.7% | -71.9% | – | – |
| Cost of Goods Sold | $14,305 | $21,638 | $30,142 | $100 |
| Gross Profit | -$14,295 | -$18,830 | -$20,142 | -$100 |
| % Margin | -146,110.2% | -670.6% | -201.4% | – |
| R&D Expenses | $14,205 | $21,538 | $30,042 | $30,618 |
| G&A Expenses | $8,356 | $11,310 | $10,643 | $7,790 |
| SG&A Expenses | $9,156 | $11,910 | $11,243 | $8,351 |
| Sales & Mktg Exp. | $800 | $600 | $600 | $561 |
| Other Operating Expenses | -$14,205 | -$21,338 | -$30,042 | $0 |
| Operating Expenses | $9,156 | $12,110 | $11,243 | $38,969 |
| Operating Income | -$23,451 | -$30,940 | -$31,385 | -$39,069 |
| % Margin | -239,692.2% | -1,101.9% | -313.9% | – |
| Other Income/Exp. Net | $19,398 | $778 | $438 | $372 |
| Pre-Tax Income | -$4,054 | -$30,161 | -$30,948 | -$38,696 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4,054 | -$30,161 | -$30,948 | -$38,696 |
| % Margin | -41,430.9% | -1,074.2% | -309.5% | – |
| EPS | -0.48 | -4.15 | -4.39 | -7.52 |
| % Growth | 88.4% | 5.5% | 41.6% | – |
| EPS Diluted | -0.48 | -4.15 | -4.39 | -7.52 |
| Weighted Avg Shares Out | 8,497 | 7,275 | 7,048 | 5,096 |
| Weighted Avg Shares Out Dil | 8,497 | 7,275 | 7,048 | 5,096 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $42 | $38 | $24 | $26 |
| EBITDA | -$23,409 | -$30,702 | -$31,361 | -$39,042 |
| % Margin | -239,259.6% | -1,093.4% | -313.6% | – |